These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10656128)

  • 1. [Current approaches to the diagnosis and correction of atherogenic disorders in flight personnel].
    Orlova TA; Khudov VV; Bobrovnitskiĭ IP
    Aviakosm Ekolog Med; 1999; 33(6):3-11. PubMed ID: 10656128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperlipidemia and decrease of lipid tolerance as factors of atherogenesis].
    Ambroskina VV; Kriachok TA; Larionov OP; Talaieva TV; Bratus' VV
    Fiziol Zh (1994); 2007; 53(6):19-28. PubMed ID: 18309627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indicators of lipid metabolism and lipid peroxidation system in patients with different types of lesions of the vessels of the lower limbs].
    Davidenkova EF; Liberman IS; Mel'nikova VP; Goriachkov AIu; Tazitdinova LK
    Klin Med (Mosk); 1992; 70(5-6):39-42. PubMed ID: 1434397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possible effect of hyperlipidemia on the development and course of atherosclerosis in flight personnel].
    Mukhamedov EG; Pukach LP; Veklich OK; Arsent'ev BA; Sorokina AV
    Voen Med Zh; 1985 Oct; (10):47-9. PubMed ID: 4072041
    [No Abstract]   [Full Text] [Related]  

  • 5. [Which lipid parameters are atherogenic? Pathological lipid values and their therapeutic consequences].
    Thomas HP; Steinhagen-Thiessen E
    MMW Fortschr Med; 1999 Sep; 141(37):34-6. PubMed ID: 10897971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the importance of biochemical testing of lipid metabolism in the diagnosis of early forms of atherosclerosis in flight personnel].
    Gel'man BL; Kuznetsova LI
    Voen Med Zh; 1966 Sep; 9():62-5. PubMed ID: 5995656
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lipid metabolism and atherosclerosis risk in renal diseases in pediatric age].
    Ferrara P; Ruggiero A; Pulitanò S; Vacca P; Venuti L; Salvaggio E
    Minerva Pediatr; 1998 Dec; 50(12):513-8. PubMed ID: 10210942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AACE medical guidelines for clinical practice for the diagnosis and treatment of dyslipidemia and prevention of atherogenesis.
    Jellinger PS; Dickey RA; Ganda OP; Mehta AE; Nguyen TT; Rodbard HW; Seibel JA; Shepherd MD; Smith DA;
    Endocr Pract; 2000; 6(2):162-213. PubMed ID: 11428356
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biochemical methods of diagnosing early forms of atherosclerosis in flight personnel].
    Kuznetsova LI
    Voen Med Zh; 1970 Jan; 1():60-1. PubMed ID: 5438536
    [No Abstract]   [Full Text] [Related]  

  • 10. [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy].
    Dobiásová M; Frohlich J
    Vnitr Lek; 2000 Mar; 46(3):152-6. PubMed ID: 11048517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipid peroxidation in the etiology and pathogenesis of atherosclerosis].
    Lankin VZ; Bikhert AM
    Arkh Patol; 1989; 51(1):80-4. PubMed ID: 2655565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there any relationship between lipids and vitamin B levels in persons with elevated risk of atherosclerosis?
    Wasilewska A; Narkiewicz M; Rutkowski B; Łysiak-Szydłowska W
    Med Sci Monit; 2003 Mar; 9(3):CR147-51. PubMed ID: 12640345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The atherogenic potential. Critical survey on the relation between lipids and atherogenesis].
    Scandigli G; Spigai C
    G Gerontol; 1968 Apr; 16(4):347-61. PubMed ID: 4886484
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of disorders of lipid metabolism--gastroenterologic aspects].
    Steinmetz A
    Z Arztl Fortbild (Jena); 1992 May; 86(9):437-44. PubMed ID: 1318619
    [No Abstract]   [Full Text] [Related]  

  • 15. [The significance of the determination of apoproteins in the diagnosis of lipoprotein metabolism disorders].
    Lepsanović L
    Med Pregl; 1990; 43(1-2):61-8. PubMed ID: 2215396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparison of the results of the surgical and the conservative corrections of hyperlipidemia in treating atherosclerosis].
    Ratner GL; Kalimullin KhA
    Vestn Khir Im I I Grek; 1995; 154(4-6):31-3. PubMed ID: 9027043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid lowering therapy in atherosclerosis.
    Aikawa M; Libby P
    Semin Vasc Med; 2004 Nov; 4(4):357-66. PubMed ID: 15861316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of a 3-hydroxypyridine-class antioxidant on disorders of the microcirculatory system in experimental dyslipoproteinemia and its alimentary correction].
    Klimenko ED; Kobozeva LP; Michunskaia AB; Zolotov NN; Khabarina IIu; Pozdniakov OM
    Biull Eksp Biol Med; 1990 Mar; 109(3):234-7. PubMed ID: 2364144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atherosclerosis: some topical issues of pathogenesis, diagnosis, treatment and prevention].
    Karpov RS; Dudko VA
    Klin Med (Mosk); 1999; 77(12):9-13. PubMed ID: 10684207
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anthropo-ecological aspects of occupational health and various biochemical approaches to the problem of its evaluation in workers in high risk occupations].
    Bobrovnitskiĭ IP; Ponomarenko VA
    Kosm Biol Aviakosm Med; 1991; 25(2):31-6. PubMed ID: 1870314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.